Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Merck & Co. discovers another potent and selective COX-2 inhibitor

Sep. 11, 1998

SB reports on potent analgesics with fewer side effects

Sep. 11, 1998

Preclinical and clinical data support potential of MKC-733 in GI motor disorders

Sep. 11, 1998

Clinical studies on Hoe-901 reported at European diabetes meeting

Sep. 11, 1998

Dimethoxy quinazoline derivative WHI-P180 inhibits mast cell mediator release

Sep. 11, 1998

DuPont identifies SP-904 as potent and selective CRF1 receptor antagonist

Sep. 11, 1998

DDE-131: new apoptosis-inducing antitumor agent from WHI

Sep. 11, 1998

Merck Frosst reveals discoveries in the field of COX-2 inhibitors at ACS meeting

Sep. 11, 1998

Biaryl uricosuric agents developed at Kotobuki

Sep. 11, 1998

Kotobuki selects development candidate from novel series with selectivity for COX-2

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...